Masashi Kondo
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 2%
- Physiology top 5%
- Cancer Research top 2%
- Co-authors
- Yoshinori HasegawaYoshitaka SekidoKaoru ShimokataSatoru ItoHiroaki KumeTakashi TakahashiJohn D. MinnaAdi F. Gazdar
- Topics
- Lung Cancer Treatments and Mutations (32 papers)Lung Cancer Diagnosis and Treatment (22 papers)Asthma and respiratory diseases (17 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Masashi Kondo
188 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Molecular Biology 3.0k
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.1k
- Physiology 693
- Cancer Research 686
Countries citing papers authored by Masashi Kondo
This map shows the geographic impact of Masashi Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Kondo more than expected).
Fields of papers citing papers by Masashi Kondo
This network shows the impact of papers produced by Masashi Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Kondo. The network helps show where Masashi Kondo may publish in the future.
Co-authorship network of co-authors of Masashi Kondo
This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Kondo. A scholar is included among the top collaborators of Masashi Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Kondo. Masashi Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 6 | |
| 12 | 13 | |
| 13 | 17 | |
| 14 | Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906. | 4 |
| 15 | 22 | |
| 16 | Genetic polymorphisms of the adenosine triphosphate-binding cassette transporters (ABCG2, ABCB1) and gefitinib toxicity. | 36 |
| 17 | 32 | |
| 18 | 23 | |
| 19 | 13 | |
| 20 | 5 |
About Masashi Kondo
Masashi Kondo is a scholar working on Pulmonary and Respiratory Medicine, Sensory Systems and Immunology and Allergy, having authored 199 papers that have together received 5.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (22 papers) and Asthma and respiratory diseases (17 papers). The work is most often cited by research in Cancer Research (686 citations), Molecular Biology (3.0k citations) and Pulmonary and Respiratory Medicine (1.4k citations). Masashi Kondo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yoshinori Hasegawa, Yoshitaka Sekido, Kaoru Shimokata, Satoru Ito, Hiroaki Kume, Takashi Takahashi, John D. Minna, Adi F. Gazdar, Masahiro Sokabe and Mitsuo Sato. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Neuron.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.